Publikasi Scopus FKUI 2021 per tanggal 30 Juni 2021 (428 artikel)

Hariyanto H., Yahya C.Q., Aritonang R.C.A.
55906967200;57190857039;57219610092;
Severe COVID-19 in the intensive care unit: a case series
2021
Journal of Medical Case Reports
15
1
259
Faculty of Medicine, Department of Anesthesiology and Intensive Care, Universitas Pelita Harapan, Jl. M. H. Thamrin Boulevard 1100, Lippo Village Tangerang, Tangerang, Banten 15811, Indonesia; Faculty of Medicine, Universitas Indonesia, Jalan Diponegoro No 77, Jakarta Pusat, 10430, Indonesia; Siloam Hospitals Kelapa Dua, Jl. Kelapa Dua Raya No.1001, Kelapa Dua, Tangerang, Banten 15810, Indonesia
Hariyanto, H., Faculty of Medicine, Department of Anesthesiology and Intensive Care, Universitas Pelita Harapan, Jl. M. H. Thamrin Boulevard 1100, Lippo Village Tangerang, Tangerang, Banten 15811, Indonesia, Siloam Hospitals Kelapa Dua, Jl. Kelapa Dua Raya No.1001, Kelapa Dua, Tangerang, Banten 15810, Indonesia; Yahya, C.Q., Faculty of Medicine, Universitas Indonesia, Jalan Diponegoro No 77, Jakarta Pusat, 10430, Indonesia; Aritonang, R.C.A., Faculty of Medicine, Department of Anesthesiology and Intensive Care, Universitas Pelita Harapan, Jl. M. H. Thamrin Boulevard 1100, Lippo Village Tangerang, Tangerang, Banten 15811, Indonesia, Siloam Hospitals Kelapa Dua, Jl. Kelapa Dua Raya No.1001, Kelapa Dua, Tangerang, Banten 15810, Indonesia
Background: Coronavirus disease 2019 (COVID-19) was first identified in Indonesia in March 2020, and the number of infections has grown exponentially. The situation is at its worst, overwhelming intensive care unit (ICU) resources and capacity. Case presentation: This is a single-center observational case study of 21 confirmed COVID-19 patients admitted to the ICU from March 20, 2020, to April 31, 2020. Demographics, baseline comorbidities, clinical symptoms, laboratory tests, electrocardiogram (ECG) and chest imaging were obtained consecutively during patient care. We identified 21 patients with confirmed COVID-19 severe infection in our ICU. The mean (± standard deviation) age of the patients was 54 ± 10 years; 95% were men, with shortness of breath (90.6%) the most common symptom. Hypertension was identified as a comorbidity in 28.6% of patients. The most common reason for admission to the ICU was hypoxemic respiratory failure, with 80% (17 patients) requiring mechanical ventilation. Half of the patients (10) died between day 1 and day 18, with septic shock as the primary cause of death. Of the 11 surviving patients, five were discharged home, while six were discharged from the ICU but remained in the hospital ward. Even then, the median length of ICU stay amongst survivors was 18 days. Conclusions: To date, there are no known effective antiviral agents or specific therapy to treat COVID-19. As severe systemic inflammatory response and multiple organ failure seems to be the primary cause of death, supportive care in maintaining oxygenation and hemodynamic stability remain the mainstay goals in treating critically ill COVID-19 patients. © 2021, The Author(s).
Case report; COVID-19; ICU; Mechanical ventilation; Respiratory failure; Septic shock; Severe infection
alanine aminotransferase; antifungal agent; aspartate aminotransferase; azithromycin; C reactive protein; heparin; hydroxychloroquine; lactate dehydrogenase; meropenem; tocilizumab; adult; aged; alanine aminotransferase blood level; Article; artificial ventilation; aspartate aminotransferase blood level; case study; cause of death; clinical article; clinical feature; comorbidity; computer assisted tomography; coronavirus disease 2019; coughing; critically ill patient; disease duration; disease severity; dyspnea; electrocardiogram; erythrocyte sedimentation rate; fatigue; female; fever; ground glass opacity; hospital admission; hospital discharge; human; hypertension; hypoxemic respiratory failure; Indonesia; intensive care unit; intubation; laboratory test; lactate dehydrogenase blood leve
BioMed Central Ltd
17521947
33941249
Article
Q3
255
16005